Flossie Wong-Staal died in San Diego, California, on July 8, 2020, at age 73, following a groundbreaking career in HIV/AIDS molecular biology.
Flossie Wong-Staal died on July 8, 2020, in San Diego, California, at the age of 73. Her death was noted with tributes from institutions including the National Institutes of Health, where she had spent formative years of her career, and the University of California, San Diego, where she later held academic and research leadership positions.
Colleagues and historians remembered her not only for her landmark scientific achievements — including her role in the discovery of the first human retrovirus HTLV-1 and her historic 1985 cloning of HIV — but also for her decades-long dedication to translating basic virology research into clinical tools and therapies. In her later career, she pivoted to hepatitis C research and co-founded iTherX Pharmaceuticals, extending her scientific legacy into new therapeutic frontiers.
Tributes published by NIH's Intramural Research Program and the Daily Bruin (her alma mater UCLA's student newspaper) highlighted her as a trailblazing woman and immigrant scientist who broke barriers in a field dominated by men, and whose work fundamentally altered the trajectory of the AIDS epidemic response.
Her death marked the loss of one of the most consequential molecular virologists of the twentieth century, whose fundamental discoveries about HIV's genetic structure continue to underpin diagnostic and therapeutic advances against the virus to this day.